This indefinite delivery contract (IDC) was awarded by the Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc., a minority-owned, small disadvantaged business and economically disadvantaged woman-owned small business. The single-award IDC has a ceiling value of $143,284,854.50 and a period of performance from September 24, 2020 to September 23, 2025, with a one-year base period and four one-year option periods.
The contract is for the supply of losartan potassium tablets in various pack sizes to support the VA, Department of Defense (DoD), Bureau of Prisons, and Indian Health Service. The estimated annual requirements for the nine line items range from 33,710 to 547,370 bottles. This procurement was conducted as an unrestricted, full and open competition. The contract items will be distributed through the VA's and DoD's respective pharmaceutical prime vendor programs.
Generated 8/29/24, 9:09 AM